Endocrinology Research and Practice
Case Report

Newly Diagnosed Type 1 Diabetes Presenting with Diabetic Ketoacidosis After SARS-CoV-2 Vaccine


Department of Internal Medicine, Acıbadem University Faculty of Medicine, İstanbul, Turkey

Endocrinol Res Pract 2023; 27: 33-35
DOI: 10.5152/erp.2023.22125
Read: 476 Downloads: 144 Published: 19 January 2023

The COVID-19 pandemic has deeply affected the whole world in the last 3 years due to the mortality and morbidity it causes. Billions of doses of vaccines have been administered to overcome the pandemic. The increased incidence of various autoimmune diseases during the pandemic has given rise to the thought that COVID-19 infection or vaccine may be the triggering factor. Recently, new-onset autoimmune phenomena after COVID-19 vaccination have been reported for some autoimmune diseases like Guillain–Barré syndrome and other neurological autoimmune diseases, IgA nephropathy, rheumatoid arthritis and systemic lupus erythematosus, immune thrombotic thrombocytopenia, autoimmune liver diseases, and autoimmune thyroid diseases. Here, we present a case of newly diagnosed type 1 diabetes that developed 1 month after the SARS-CoV-2 vaccine.

Cite this article as: Köse M, Anaforoğlu İ. Newly diagnosed type 1 diabetes presenting with diabetic ketoacidosis after SARS-CoV-2 vaccine. Endocrinol Res Pract. 2023;27(1):33-35.

EISSN 2822-6135